Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide for stress hyperglycemia in sepsis
ChiCTR2100042480Phase 4Not yet recruiting
- Sponsor
- Sichuan Provincial People's Hospital
- Start
- Jan 2021
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of liraglutide in sepsis, Stress Hyperglycemia (SH) and type 2 diabetes mellitus (T2DM), sponsored by Sichuan Provincial People's Hospital. Primary endpoint: Continuous glucose monitoring metrics. Planned start Jan 2021; status: not yet recruiting.
02
Drugs
03
Conditions
sepsisStress Hyperglycemia (SH)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR2100042480.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100042480.